New Leaf Venture Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 4
- Investments
- 234
- Portfolio
- 30
- Exits
- 149
New Leaf Venture General Information
Description
Founded in 2005, New Leaf Venture Partners is a venture capital firm based in New York, New York. The firm is focused on healthcare technology-focused and seeks to invest in the biopharmaceutical, information convergence, medical device, biological research, life science tool and infrastructure sectors.
Contact Information
Website
Year Founded
2005
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 420 Lexington Avenue
- Suite 408
- New York, NY 10170
- United States
+1 (646) 000-0000
New Leaf Venture Investments (234)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| TigerConnect | 08-Oct-2020 | Later Stage VC | 0000 | Enterprise Systems (Healthcare) | Generating Revenue | 00000 00000 |
| 000000 000 | 14-Sep-2020 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | |
| 0000000 | 25-Aug-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 0000 |
| 0000000 | 10-Aug-2020 | 0000 | 000.00 | Drug Delivery | Generating Revenue/Not Profitable | |
| 0000000 000 | 15-Jul-2020 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
| 0000000000000 | 10-Jun-2020 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue | 00000 00000 |
| 00000000 | 19-May-2020 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | 000000 0000 |
| 000000 | 07-Nov-2019 | 00000 00000 | 000.00 | Outcome Management (Healthcare) | Generating Revenue | 00000 00000 |
| Edgewise Therapeutics | 17-Sep-2019 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue | |
| Passage Bio | 04-Sep-2019 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 0000 000000000 00.0 |
New Leaf Venture Exits (149)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Calchan | 06-Nov-2020 | Out of Business | |
| 000000 00000000000 | 26-Oct-2020 | 000000 0000000000 | 000.00 |
| 000000000 00000000 | 28-Sep-2020 | 000000000000000000 | 00.000 |
| 0000000 000 | 28-Feb-2020 | 000 | 00000 |
| 000000000 | 13-Feb-2020 | 000000000 00000000 | 00000 |
| 0000000 | 13-Jan-2020 | 000000 0000000000 | 000.00 |
| 0000000 | 30-Oct-2019 | 0000000000: 000000 | |
| 0000 000000000000 | 18-Mar-2019 | 000000000000000000 | |
| Harpoon Therapeutics | 08-Feb-2019 | IPO | 0000 |
| Alector | 07-Feb-2019 | IPO | 00000 |
New Leaf Venture Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNew Leaf Venture Team (47)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Craig Slutzkin | Chief Financial Officer & Chief Operating Officer | New York, NY | |||
| James Niedel Ph.D | Venture Partner | 00 | 0 | New York, NY | |
| Ronald Hunt | Co-Founder & Managing Director | 00 | 0 | 0 | New York, NY |
| Vijay Lathi | Co-Founder & Managing Director | 00 | 0 | 0 | Menlo Park, CA |
| Jeffrey Ives Ph.D | Venture Partner | 0 | New York, NY |
New Leaf Venture Co-Investors (170)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 8 | 0 | 0 |
|
|
| Canaan Partners | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|
|
| Frazier Healthcare Partners | 0 | 0 |
|
|
|
| Polaris Partners | 0 | 0 |
|
|